16 April 2021>: Original Paper
Efficacy and Safety of Once-Daily LCP-Tacrolimus Versus Twice-Daily Immediate-Release Tacrolimus in Adult Hispanic Stable Kidney Transplant Recipients: Sub-Group Analysis from a Phase 3 Trial
Arman Faravardeh 1DE* , Sanjeev Akkina 2DE , Rafael Villicana 3DE , Giselle Guerra 4DE , Misbah A. Moten 5ADE , Ulf Meier-Kriesche 5ADE , Daniel R. Stevens 5ACDE , Samir J. Patel 5DE , Suphamai Bunnapradist 6DEDOI: 10.12659/AOT.929535
Ann Transplant 2021; 26:e929535
Figure 1 Patient disposition. AE – adverse event; IR-Tac – immediate-release tacrolimus; LCPT – LCP-tacrolimus.